Imdelltra TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tarlatamab
Brand name
(ARTG)
: IMDELLTRA tarlatamab 1 mg powder for injection vial with intravenous (IV) solution stabiliser vial composite packWhat this medicine is used for
(ARTG)
Imdelltra has provisional approval in Australia for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy. The decision to approve this indication has been made on the basis of overall response rate and duration of response in a single arm trial. Continued approval of this indication depends on verification and description of benefit in confirmatory trials.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous Infusion
- White to slightly yellow lyophilised powder.
Component :
- Injection, solution
- Intravenous Infusion
- Colourless to slightly yellow, and clear to slightly opalescent solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Store in Original Container
- Shelf lifetime is 18 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial with 2 intravenous (IV) solution stabiliser vials pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
